Stock Earnings Recent Insider Activity Could Benefit Syndax Pharmaceuticals Inc (SNDX) Syndax Pharmaceuticals Inc’s recently made public that its Chief Financial Officer Goldan Keith A. unloaded Company’s shares for reported $12033.0
Analysts Viewpoint Syndax Pharmaceuticals Inc [SNDX] Investment Appeal on the Rise In a filing, Syndax Pharmaceuticals Inc revealed its Head of R&D, CMO Botwood Nicholas A.J. acquired Company’s shares for reported